BULLETIN V2026-1952
SHARP THERAPEUTICS CORP. ("SHRX")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: June 8, 2026
TSX Venture Tier 2 Company
Financing Type: Non-Brokered Private Placement
Offering: US$1,550,000 principal amount of convertible debenture, convertible into 775,000 Listed Shares
Conversion Price: US$2.00 per Listed Share
Maturity date: 12 months from issuance
Interest rate: 6% per annum
Disclosure: Refer to the company's news releases dated February 2, 2026, February 27, 2026, March 13, 2026, April 2, 2026, April 10, 2026, and April 17, 2026.
_______________________________________
|
|
